The France Veterinary Healthcare market is expected to register a CAGR of around 4% during the forecast period, 2018 to 2023. Veterinary medicines are associated with treatment, diagnosis, and prevention of diseases among animals. It covers a variety of animal species, both, in domestic and wild.
Increasing Productivity at the Risk of Emerging Zoonosis
The growing meat consumption, especially for chicken and pork, is adding to the exposure of dangerous foodborne pathogens. The E. coli and Salmonella infections cause serious diseases among people, and can even be fatal at times, which is possible during the intensive production systems. Moreover, there is a risk of emerging new strains of influenza viruses, due to the long distance transportation of animals. The farms are often in the same area, with a concentration of confined animals, which potentially enhances the risk of avian influenza transferring to pigs. The reassortment of the virus can lead to new strains and cause infections among humans. Further, these farms increase the risk of spreading and mixing of virus strains. Intensive farm practices are causing the risk of emergence of these bacteria in the food, as stressed animals become more susceptible to infection. The risk from zoonotic diseases is fuelling the market for France veterinary healthcare. Inter-Governmental Organizations and the food production are making reforms to ensure health by the process of surveillance and vaccination, investing in R&D, and transfer with respect to vet health.
Additionally, advanced technology leading to innovations in animal healthcare is also a factor responsible for the growth of France veterinary healthcare market.
Increasing Costs of Animal Testing and Veterinary Services
Advances in veterinary care over the past few years have come at high price. For instance, costs to treat a torn Anterior Cruciate Ligament (ACL), a common dog injury, have soared to costs above 2,000 euros, which is more than double the money people had paid in past. That doesn't include the costs of diagnostic testing, which can add an additional cost to a pet owner's bill. Also, many diseases and injuries are diagnosed with an MRI, which used to be inaccessible to all but the most well-funded university hospitals. That MRI machines are available in many hospitals, vets use this test as standard care for diagnosing and treating cancer, epilepsy, injury, etc., but the test itself also costs around 600 plus euros as this is an incredibly useful and important diagnostic tool, the cost is out of reach for many pet owners who would struggle to be able to afford the surgery and/or treatment following the MRI, let alone the cost of the test itself. Thus, increasing cost of animal testing and veterinary services is hindering the growth of the market.
Also, lack of infrastructure and funding and use of counterfeit medicines are restraining the growth of France veterinary healthcare market.
Vaccines is expected to lead the Market
The Vaccines segment in France veterinary healthcare market is expected to register a healthy CAGR during the forecasted period due to the presence of good healthcare infrastructure in the France and it is also experiencing positive trends in the R&D developments.
Key Developments in the Market:
- June 2018: Elanco Animal Health introduced New Respiratory PRRS Vaccine, a modified-live respiratory vaccine, which is effective in the reduction of porcine reproductive and respiratory syndrome (PRRS), respiratory form, in piglets two weeks or older
Major Players: Abaxis, Zoetis animal healthcare, Merck, Elanco, Bayer healthcare, Ceva Animal Health, Inc., and Boehringer Ingelheim, amongst others.
Reasons to Purchase this Report
- Current and future France veterinary healthcare market outlook in the developed and emerging markets
- Analyzing various perspectives of the market with the help of Porter’s five forces analysis
- The segment that is expected to dominate the market
- Regions that are expected to witness fastest growth during the forecast period
- Identify the latest developments, market shares, and strategies employed by the major market players.
- 3-month analyst support, along with the Market Estimate sheet in excel
Customization of the Report
- This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porters Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Driver
6.1.1 Advanced Technology Leading to Innovations in Animal Healthcare
6.1.2 Risk of Emerging Zoonosis
6.2 Market Restraint
6.2.1 Lack of Infrastructure and Funding
6.2.2 Use of Counterfeit Medicines
6.2.3 Increasing Costs of Animal Testing and Veterinary Services
7. Market Segmentation
7.1 By Product Type
7.1.1 By Therapeutics
22.214.171.124 Medical Feed Additives
7.1.2 By Diagnostics
126.96.36.199 Immunodiagnostic Tests
188.8.131.52 Molecular diagnostics
184.108.40.206 Diagnostic Imaging
220.127.116.11 Clinical Chemistry
7.2 By Animal Type
7.2.1 Farm animal
7.2.2 Companion Animal
18.104.22.168 Dogs and Cats
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.2 Bayer healthcare
9.3 Boehringer Ingelheim
9.4 Ceva Animal Health, Inc.
9.5 Elanco (Eli Lilly and Company)
9.7 Zoetis animal healthcare
**List Not Exhausitive
10. Future of the Market